MedTrace Logo

PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella

NCT05253976 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-12-24

No results posted yet for this study

Summary

The study is a single-center, retrospective and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the NexGen TM Augmentation Patella. The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.

The secondary objective is the assessment of performance and clinical benefits by recording patient-reported clinical outcome measures (PROMs) as well as radiographic outcomes.

Conditions

  • Rheumatoid Arthritis
  • Non-inflammatory Degenerative Joint Disease
  • Functional Deformity
  • Revision Total Knee Arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2034-12-31
Completion
2034-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05253976 on ClinicalTrials.gov